Search

everythinglearnresearchcommunity

for

Search:↓

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

A new method effectively predicts estrogen-related health effects for early screening.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

Finasteride increases P-glycoprotein activity in the liver and kidney.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Minoxidil boosts hair growth by activating PGHS-1.

Activated platelet-rich plasma helps hair growth by boosting growth factors and cell growth pathways in hair cells.

Human liver enzyme DHEA ST helps process minoxidil.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

A new peptide delivered through microneedles can effectively promote hair regrowth.

Psychotropic drugs can interact with natural products, affecting their effectiveness and safety.

Nandrolone phenylpropionate injections thickened the skin and enlarged oil glands in female hairless hamsters.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Bone mineral and minocycline boost bone cell growth, aiding healing.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

Trazodone might help reverse post finasteride syndrome.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

PDRN is effective and safe for healing wounds and skin issues.

PEVs improve minoxidil skin penetration, increasing hair growth.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Overexpressing SSAT in mice makes them highly sensitive to polyamine analogues, causing liver damage and high mortality.